tirzepatide vs semaglutide differences mechanism vs. for Obesity Is Tirzepatide Better Than Semaglutide

In a recent study published in the Journal of Medical Economics , a group of researchers evaluated the cost-effectiveness of tirzepatide compared with semaglutide for adults with obesity or overweight in the United States (U.S.) using a lifetime simulation model informed by the SURMOUNT-5 head-to-head trial population without type 2 diabetes (T2D)

Since semaglutide is a GLP-1 agonist, it mimics the actions of GLP-1, producing these same effects

CJC-1295 with DAC suits researchers who prioritize convenience and sustained IGF-1 elevation

Broader Implications for High-Risk Populations This study supports the use of GLP-1RA in patients with lupus and T2D, including those with lupus nephritis